23andMe, a popular South San Francisco-based genetic testing company, is laying off 40% of its workers after struggling with ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
Preventative speciality can diagnose rare and inherited health conditions but difficulty accessing the service is affecting ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival. The once-popular DNA-testing site will also halt work on therapies it ...
Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares. Chicago-based Tempus, which makes AI-enabled precision medicine solutions ...